MYSTIC: Developing biomarkers for metastatic NSCLC

TATTON: Updated results for patients with EGFR-mutant NSCLC

Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours

Immune checkpoint inhibitor combination efficacious for patients with high-grade neuroendocrine carcinoma

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma

Cancer preventive vaccine showed promising results in preclinical model of Lynch syndrome

Umbralisib shows early promise for patients with marginal zone lymphoma

KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer

Gilteritinib improved survival for patients with acute myeloid leukaemia

Clinical trials in Africa: Bench to bedside

Improving cancer care in Nigeria

Personalised research for cancer care in Africa